Global Cephalosporin Market Insights, Research Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 129

Report ID: 5439

The global Cephalosporin market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cephalosporin market based on company, product type, end user and key regions.

This report studies the global market size of Cephalosporin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cephalosporin in these regions.
This research report categorizes the global Cephalosporin market by top players/brands, region, type and end user. This report also studies the global Cephalosporin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Union Chempharma
Qilu Antibiotics
Lupin Pharmaceuticals
Dhanuka Laboratories
Dongying Pharmaceutical
Hetero Drugs
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories

Market size by Product
First Generation
Second Generation
Third Generation
Fourth Generation
Market size by End User

Market size by Region
North America
United States
South Korea
Central & South America
Rest of Central & South America
Middle East & Africa
GCC Countries
South Africa

The study objectives of this report are:
To study and analyze the global Cephalosporin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cephalosporin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cephalosporin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cephalosporin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Cephalosporin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cephalosporin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Cephalosporin Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Cephalosporin Market Size Growth Rate by Product
1.4.2 First Generation
1.4.3 Second Generation
1.4.4 Third Generation
1.4.5 Fourth Generation
1.5 Market by End User
1.5.1 Global Cephalosporin Market Size Growth Rate by End User
1.5.2 Oral
1.5.3 Injection
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Cephalosporin Market Size
2.1.1 Global Cephalosporin Revenue 2014-2025
2.1.2 Global Cephalosporin Sales 2014-2025
2.2 Cephalosporin Growth Rate by Regions
2.2.1 Global Cephalosporin Sales by Regions
2.2.2 Global Cephalosporin Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Cephalosporin Sales by Manufacturers
3.1.1 Cephalosporin Sales by Manufacturers
3.1.2 Cephalosporin Sales Market Share by Manufacturers
3.1.3 Global Cephalosporin Market Concentration Ratio (CR5 and HHI)
3.2 Cephalosporin Revenue by Manufacturers
3.2.1 Cephalosporin Revenue by Manufacturers (2014-2019)
3.2.2 Cephalosporin Revenue Share by Manufacturers (2014-2019)
3.3 Cephalosporin Price by Manufacturers
3.4 Cephalosporin Manufacturing Base Distribution, Product Types
3.4.1 Cephalosporin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cephalosporin Product Type
3.4.3 Date of International Manufacturers Enter into Cephalosporin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Cephalosporin Sales by Product
4.2 Global Cephalosporin Revenue by Product
4.3 Cephalosporin Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Cephalosporin Breakdown Data by End User

6 North America
6.1 North America Cephalosporin by Countries
6.1.1 North America Cephalosporin Sales by Countries
6.1.2 North America Cephalosporin Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Cephalosporin by Product
6.3 North America Cephalosporin by End User

7 Europe
7.1 Europe Cephalosporin by Countries
7.1.1 Europe Cephalosporin Sales by Countries
7.1.2 Europe Cephalosporin Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cephalosporin by Product
7.3 Europe Cephalosporin by End User

8 Asia Pacific
8.1 Asia Pacific Cephalosporin by Countries
8.1.1 Asia Pacific Cephalosporin Sales by Countries
8.1.2 Asia Pacific Cephalosporin Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Cephalosporin by Product
8.3 Asia Pacific Cephalosporin by End User

9 Central & South America
9.1 Central & South America Cephalosporin by Countries
9.1.1 Central & South America Cephalosporin Sales by Countries
9.1.2 Central & South America Cephalosporin Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Cephalosporin by Product
9.3 Central & South America Cephalosporin by End User

10 Middle East and Africa
10.1 Middle East and Africa Cephalosporin by Countries
10.1.1 Middle East and Africa Cephalosporin Sales by Countries
10.1.2 Middle East and Africa Cephalosporin Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Cephalosporin by Product
10.3 Middle East and Africa Cephalosporin by End User

11 Company Profiles
11.1 Union Chempharma
11.1.1 Union Chempharma Company Details
11.1.2 Company Business Overview
11.1.3 Union Chempharma Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Union Chempharma Cephalosporin Products Offered
11.1.5 Union Chempharma Recent Development
11.2 NCPC
11.2.1 NCPC Company Details
11.2.2 Company Business Overview
11.2.3 NCPC Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
11.2.4 NCPC Cephalosporin Products Offered
11.2.5 NCPC Recent Development
11.3 Qilu Antibiotics
11.3.1 Qilu Antibiotics Company Details
11.3.2 Company Business Overview
11.3.3 Qilu Antibiotics Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Qilu Antibiotics Cephalosporin Products Offered
11.3.5 Qilu Antibiotics Recent Development
11.4 Lupin Pharmaceuticals
11.4.1 Lupin Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Lupin Pharmaceuticals Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Lupin Pharmaceuticals Cephalosporin Products Offered
11.4.5 Lupin Pharmaceuticals Recent Development
11.5 Hospira
11.5.1 Hospira Company Details
11.5.2 Company Business Overview
11.5.3 Hospira Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Hospira Cephalosporin Products Offered
11.5.5 Hospira Recent Development
11.6 Dhanuka Laboratories
11.6.1 Dhanuka Laboratories Company Details
11.6.2 Company Business Overview
11.6.3 Dhanuka Laboratories Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Dhanuka Laboratories Cephalosporin Products Offered
11.6.5 Dhanuka Laboratories Recent Development
11.7 Fukang
11.7.1 Fukang Company Details
11.7.2 Company Business Overview
11.7.3 Fukang Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Fukang Cephalosporin Products Offered
11.7.5 Fukang Recent Development
11.8 Dongying Pharmaceutical
11.8.1 Dongying Pharmaceutical Company Details
11.8.2 Company Business Overview
11.8.3 Dongying Pharmaceutical Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Dongying Pharmaceutical Cephalosporin Products Offered
11.8.5 Dongying Pharmaceutical Recent Development
11.9 Alkem
11.9.1 Alkem Company Details
11.9.2 Company Business Overview
11.9.3 Alkem Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Alkem Cephalosporin Products Offered
11.9.5 Alkem Recent Development
11.10.1 SALUBRIS Company Details
11.10.2 Company Business Overview
11.10.3 SALUBRIS Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
11.10.4 SALUBRIS Cephalosporin Products Offered
11.10.5 SALUBRIS Recent Development
11.11 LIVZON
11.12 Hetero Drugs
11.13 CSPC
11.14 TEVA
11.15 Orchid Pharma
11.16 Taj Pharmaceuticals
11.17 Covalent Laboratories
11.18 United Laboratories
11.19 Aurobindo
11.20 Wockhardt
11.21 LKPC
11.22 HPGC
11.23 Huafangpharm

12 Future Forecast
12.1 Cephalosporin Market Forecast by Regions
12.1.1 Global Cephalosporin Sales Forecast by Regions 2019-2025
12.1.2 Global Cephalosporin Revenue Forecast by Regions 2019-2025
12.2 Cephalosporin Market Forecast by Product
12.2.1 Global Cephalosporin Sales Forecast by Product 2019-2025
12.2.2 Global Cephalosporin Revenue Forecast by Product 2019-2025
12.3 Cephalosporin Market Forecast by End User
12.4 North America Cephalosporin Forecast
12.5 Europe Cephalosporin Forecast
12.6 Asia Pacific Cephalosporin Forecast
12.7 Central & South America Cephalosporin Forecast
12.8 Middle East and Africa Cephalosporin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cephalosporin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer